Henry Schein News

Leerink Partners Adjusts Henry Schein's Price Target to $77 From $82, Keeps Market Perform Rating

MT NewswiresApr 12 18:17

Henry Schein Analyst Ratings

BenzingaMar 6 18:23

Jefferies Maintains Hold on Henry Schein, Raises Price Target to $81

BenzingaMar 6 18:24

Barrington Boosts Price Target on Henry Schein to $90 From $82, Keeps Outperform Rating

MT NewswiresFeb 28 23:12

Henry Schein Stock Faces Headwinds: Sell Rating Affirmed Amidst Growth and Revenue Challenges

TipRanksFeb 28 18:49

Goldman Sachs Sticks to Its Hold Rating for Henry Schein (HSIC)

TipRanksFeb 28 11:55

Henry Schein Analyst Ratings

BenzingaFeb 26 20:59

Stifel Nicolaus Upgrades Henry Schein (HSIC) to a Buy

TipRanksFeb 21 21:02

UBS Adjusts Henry Schein Price Target to $78 From $75, Maintains Neutral Rating

MT NewswiresFeb 9 01:56

Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH), RegenXBio (RGNX) and Henry Schein (HSIC)

TipRanksJan 23 01:40

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), Henry Schein (HSIC) and Palatin Technologies (PTN)

TipRanksDec 21, 2023 19:50

Analysts Conflicted on These Healthcare Names: Halozyme (HALO), Immunovant (IMVT) and Henry Schein (HSIC)

TipRanksDec 21, 2023 19:00

What 8 Analyst Ratings Have To Say About Henry Schein

BenzingaDec 12, 2023 22:00

JP Morgan Upgrades Henry Schein to Overweight, Raises Price Target to $82

BenzingaDec 12, 2023 20:44

Henry Schein Analyst Ratings

BenzingaDec 12, 2023 20:42

Goldman Sachs Keeps Their Hold Rating on Henry Schein (HSIC)

TipRanksDec 6, 2023 11:25

Analysts Are Bullish on Top Healthcare Stocks: Henry Schein (HSIC), DocGo (DCGO)

TipRanksNov 30, 2023 21:30

Stifel Reiterates Buy on Henry Schein, Maintains $75 Price Target

BenzingaNov 28, 2023 02:35

Henry Schein Analyst Ratings

BenzingaNov 28, 2023 02:33

Analysts Offer Insights on Healthcare Companies: Agilent (A), Henry Schein (HSIC) and Biogen (BIIB)

TipRanksNov 21, 2023 20:50